Seyed H Ghaffari
Overview
Explore the profile of Seyed H Ghaffari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghaffari P, Yousefi M, Aznab M, Khazan N, Yaghmaie M, Bashash D, et al.
Cell J
. 2024 Jul;
26(5):293-308.
PMID: 39066594
Objective: Despite the advances in treatment, breast cancer (BC) remains a major cause of death in women. This study aims to evaluate the prognostic significance of detecting circulating tumor cells...
2.
Younesian S, Mohammadi M, Younesian O, Momeny M, Ghaffari S, Bashash D
Heliyon
. 2024 Jun;
10(11):e32366.
PMID: 38933971
Aberrant epigenetic modifications, particularly DNA methylation, play a critical role in the pathogenesis and progression of human diseases. The current review aims to reveal the role of aberrant DNA methylation...
3.
Kashani B, Zandi Z, Pourbagheri-Sigaroodi A, Yousefi A, Ghaffari S, Bashash D
Expert Rev Anticancer Ther
. 2024 May;
24(7):493-512.
PMID: 38690706
Introduction: As a vital mechanism of survival, lymphopoiesis requires the collaboration of different signaling molecules to orchestrate each step of cell development and maturation. The PI3K pathway is considerably involved...
4.
The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells
Abutorabi E, Poursheikhani A, Kashani B, Shamsaiegahkani S, Haghpanah V, Bashash D, et al.
Mol Biol Rep
. 2023 Mar;
50(5):4073-4082.
PMID: 36877344
Background: Anaplastic thyroid cancer (ATC) is an aggressive subtype of thyroid cancer, accounting for 1 to 2% of all cases. Deregulations of cell cycle regulatory genes including cyclins, cyclin-dependent kinases...
5.
Shahkarami S, Younesian S, Rostami S, Kompani F, Bashash D, Mousavi S, et al.
Cell J
. 2023 Feb;
25(2):85-91.
PMID: 36840454
Objective: Minimal residual disease (MRD) is considered the greatest prognostic factor in acute lymphoblastic leukemia (ALL). MRD is a valuable tool for anticipating impending relapse and treatment response assessment. The...
6.
Younesian S, Yousefi A, Momeny M, Ghaffari S, Bashash D
Cells
. 2022 Nov;
11(21).
PMID: 36359835
DNA methylation is critical for the normal development and functioning of the human brain, such as the proliferation and differentiation of neural stem cells, synaptic plasticity, neuronal reparation, learning, and...
7.
Fard S, Kouchaki S, Salimian Z, Sotoudeh M, Mousavi S, Alimoghaddam K, et al.
Anticancer Agents Med Chem
. 2022 Oct;
23(7):794-806.
PMID: 36284375
Background: As epigenetic readers, Bromodomain and extraterminal domain (BET) proteins have attracted immense interest in developing novel therapies targeting this family to inhibit cancer progression. Although the impact of BRD4...
8.
Shirin M, Agharezaeei M, Alizadeh S, Bashash D, Sheikhsaran F, Chahardouli B, et al.
Asian Pac J Cancer Prev
. 2022 Sep;
23(9):3083-3092.
PMID: 36172671
Background: Mesenchymal stem cells (MSCs) have gained much more attention in cell therapy and regenerative medicine due to their immunosuppressive effects. MSCs have interaction with other immune cells, such as...
9.
Jafari-Raddani F, Davoodi-Moghaddam Z, Yousefi A, Ghaffari S, Bashash D
Cell Biochem Funct
. 2022 Sep;
40(8):800-825.
PMID: 36111699
Long noncoding RNAs (lncRNAs) are a diverse class of RNAs whose functions are widespread in all branches of life and have been the focus of attention in the last decade....
10.
Zandi Z, Kashani B, Alishahi Z, Pourbagheri-Sigaroodi A, Esmaeili F, Ghaffari S, et al.
J Cancer Res Clin Oncol
. 2022 Jan;
148(1):57-70.
PMID: 34981193
Purpose: Therapy resistance is the principal obstacle to achieving cures in cancer patients and its successful tackling requires a deep understanding of the resistance mediators. Increasing evidence indicates that tumor...